“HLTH Europe is a great platform to engage with customers in a very relaxed setup.”
João Seabra, Global Head of Enterprise Services, Siemens Healthineers
As one of the world’s leading medtech companies, connecting diagnosis and therapy through AI, Siemens Healthineers’ ambition is to become a genuine long-term partner to customers. That takes real, unhurried conversation. HLTH Europe is exactly where Siemens Healthineers has it.
After a strong first year as Title Sponsor in 2025, Siemens Healthineers returned in 2026 to do it again. This time with a bigger booth, two roundtables, a HLTH.rad workshop, and branded arrival flags to welcome Europe’s healthcare community.
The result:
When Infermedica first joined HLTH Europe in 2024, both were just getting started. HLTH Europe’s first year in the region, and Infermedica’s push to prove that AI triage could be a certified medical device, not just another chatbot. Both have grown considerably since.
Infermedica now works with government partners in more than 35 countries and supports over 26 languages. Through it all, HLTH Europe has stayed the place to make that case in person. In 2026, Infermedica returned with a booth, putting the team in direct conversation with the hospitals, health systems, and governments deciding what gets deployed.
The result:
“Every time we come to HLTH Europe, we come back with new partnerships.”
Piotr Orzechowski, CEO, Infermedica
“If you’re a provider, it’s one of the best ways to screen the market and get really qualitative interaction with the people actually making the innovation we’ll use tomorrow.”
Pierre-Yves Brossard, Head of BOpEx Innovation Hub, AP-HP
AP-HP was still building out its innovation hub when it came to Market Connect for the first time in 2025. What they needed wasn’t more companies to track, but the right ones. The businesses they don’t often see on the national market.
That first year, they used the conversations from Market Connect to shape AP-HP’s strategy and specific offerings based on the insights. This year, they reconnected with those same companies, growing relationships they’re already looking forward to continuing next year.
The result:
As a global pharmaceutical company, MSD sees engaging with the broader health ecosystem is what makes innovation happen. HLTH Europe provides MSD the direct access to the healthcare providers and innovators shaping the industry.
After 3 years attending, 2026 marked MSD’s first year with its own booth presenting MSD Idea Studio: its European program pairing the pharmaceutical company with digital health startups.
The central position on the show floor and private networking event at Strandzuid put the team in front of hospitals, insurers, startups, and venture capital firms.
The result:
“Especially in healthcare, you need this ecosystem. You cannot walk alone in order to make innovation happen.”
Jutta Klauer, Director MSD Idea Studio Europe, MSD
“We’re now well informed for our clinicians, so we can tell them what’s happening, because they’re busy taking care of patients and need that information from us.”
Maarten Walravens, Deputy CMO, AZ Sint-Maarten
Healthcare AI is moving fast, faster than most hospitals’ ten-year strategies can keep pace with, and AZ Sint-Maarten is still exploring what that shift means for its own care. That’s why they keep coming back to Market Connect: it’s the fastest way to sit down directly with the companies building what’s next.
It’s 15 minute meetings, 1-1, direct, none of the noise of the exhibition floor, and depth email or a Teams call can’t match. This year, a conversation with a speech-regonition provider was a good example. A solution that turned out to go further than they had expected.
The result:
For Roche Diagnostics, finding the right partner starts with staying curious. Martin Hund, who leads clinical development in women’s health, already knows where Roche wants to go next in the patient journey. What they needed was the people building the other pieces of it, established companies and startups alike, and HLTH Europe is where they found them.
Market Connect made the difference: it put them back in front of already established partners, and into conversations with companies they’d never have approached on his own.
The result:
“You only invest fifteen minutes with Market Connect, and you get so much out of it.”
Martin Hund, Clinical Development Lead Indication Women’s Health, Roche Diagnostics
From meeting 1-1 with health providers, to securing funding or gaining insight on where the market is heading, HLTH Europe is here to support your growth goals.
